Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Other Non-Current Liabilities (2016 - 2021)

Cardiff Oncology's Other Non-Current Liabilities history spans 11 years, with the latest figure at $5000.0 for Q3 2021.

  • For Q3 2021, Other Non-Current Liabilities fell 94.35% year-over-year to $5000.0; the TTM value through Sep 2021 reached $5000.0, down 94.35%, while the annual FY2020 figure was $285000.0, 7025.0% up from the prior year.
  • Other Non-Current Liabilities for Q3 2021 was $5000.0 at Cardiff Oncology, down from $214000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $2.0 million in Q3 2017 and bottomed at $2020.0 in Q1 2020.
  • The 5-year median for Other Non-Current Liabilities is $139726.0 (2020), against an average of $318961.4.
  • The largest annual shift saw Other Non-Current Liabilities plummeted 96.55% in 2018 before it soared 9355.45% in 2021.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $649387.0 in 2017, then plummeted by 95.02% to $32315.0 in 2018, then crashed by 87.62% to $4000.0 in 2019, then skyrocketed by 7025.0% to $285000.0 in 2020, then plummeted by 98.25% to $5000.0 in 2021.
  • Per Business Quant, the three most recent readings for CRDF's Other Non-Current Liabilities are $5000.0 (Q3 2021), $214000.0 (Q2 2021), and $191000.0 (Q1 2021).